We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
-0.36%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$5.84B
AUM Growth
-$10.1M
Cap. Flow
+$52.5M
Cap. Flow %
0.9%
Top 10 Hldgs %
63.1%
Holding
963
New
117
Increased
503
Reduced
219
Closed
73

Sector Composition

Rank Sector Weight
1 Technology 6.62%
2 Financials 3.18%
3 Healthcare 2.12%
4 Communication Services 2.02%
5 Consumer Discretionary 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICL icon
801
ICL Group
ICL
$6.8B
$172K ﹤0.01%
34,790
+13,212
+61% +$59.1K
WBA
802
DELISTED
Walgreens Boots Alliance
WBA
$171K ﹤0.01%
18,284
-13
-0.1% -$121
GFI icon
803
Gold Fields
GFI
$33.4B
$169K ﹤0.01%
12,784
-279
-2% -$4.25K
HBM icon
804
Hudbay
HBM
$11.7B
$169K ﹤0.01%
20,820
+5,064
+32% +$45.4K
VOD icon
805
Vodafone
VOD
$37B
$166K ﹤0.01%
19,598
+5,932
+43% +$54K
PUK icon
806
Prudential
PUK
$34.7B
$163K ﹤0.01%
+10,202
New +$171K
FNA
807
DELISTED
Paragon 28, Inc.
FNA
$161K ﹤0.01%
15,630
+2,043
+15% +$16.5K
LUMN icon
808
Lumen
LUMN
$6.09B
$160K ﹤0.01%
30,074
+3,868
+15% +$26.7K
ESRT icon
809
Empire State Realty Trust
ESRT
$843M
$148K ﹤0.01%
14,349
+2,668
+23% +$28.9K
SBS icon
810
Sabesp
SBS
$18.9B
$145K ﹤0.01%
+52,323
New +$160K
TAC icon
811
TransAlta
TAC
$3.95B
$145K ﹤0.01%
+10,267
New +$117K
MPT
812
Medical Properties Trust
MPT
$2.75B
$145K ﹤0.01%
36,765
-7,282
-17% -$32.6K
NUS icon
813
Nu Skin
NUS
$252M
$144K ﹤0.01%
20,856
+2,800
+16% +$19.3K
NIO icon
814
NIO
NIO
$11.5B
$137K ﹤0.01%
31,508
+7,488
+31% +$38.1K
DVAX
815
DELISTED
Dynavax Technologies
DVAX
$137K ﹤0.01%
+10,741
New +$130K
ABEV icon
816
Ambev
ABEV
$46.5B
$135K ﹤0.01%
72,759
+5,512
+8% +$12.2K
CLOV icon
817
Clover Health Investments
CLOV
$2.45B
$131K ﹤0.01%
+41,496
New +$148K
LQDA icon
818
Liquidia Corp
LQDA
$7.95B
$129K ﹤0.01%
10,960
LGTY
819
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$128K ﹤0.01%
11,583
-345
-3% -$3.76K
KRNY icon
820
Kearny Financial
KRNY
$604M
$128K ﹤0.01%
18,106
+479
+3% +$3.6K
SBH icon
821
Sally Beauty Holdings
SBH
$1.51B
$127K ﹤0.01%
12,113
+758
+7% +$9.69K
MTLS
822
Materialise
MTLS
$391M
$124K ﹤0.01%
17,668
-4,902
-22% -$32.4K
TBPH icon
823
Theravance Biopharma
TBPH
$877M
$123K ﹤0.01%
13,094
+246
+2% +$2.24K
EC icon
824
Ecopetrol
EC
$35.8B
$123K ﹤0.01%
+15,468
New +$125K
ALHC icon
825
Alignment Healthcare
ALHC
$2.78B
$121K ﹤0.01%
+10,750
New +$126K

Similar funds

Ballentine Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Ballentine Partners held 963 positions worth $5.84B, down 0.17% from $5.85B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Ballentine Partners's Q4 2024 filing shows 117 new, 503 increased, 219 reduced and 73 closed positions. Its largest new stake was iShares Core S&P US Value ETF: 20,365 shares worth $1.89M. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $8.25M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

  • Ballentine Partners's largest Q4 2024 buy was iShares Core S&P US Value ETF: 20,365 shares worth $1.89M.
  • Ballentine Partners added most to iShares Core S&P Mid-Cap ETF in Q4 2024, an estimated $5.07M increase.
  • Ballentine Partners's biggest Q4 2024 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $8.25M.
  • Ballentine Partners fully exited Huntington Ingalls Industries in Q4 2024, selling an estimated $752K.
  • Ballentine Partners's ten largest holdings make up 63% of its $5.84B portfolio in Q4 2024.
  • Ballentine Partners opened 117 new positions and closed 73 in Q4 2024.
  • Ballentine Partners's portfolio value fell 0.17% quarter-over-quarter to $5.84B.

Based on Ballentine Partners's 13F filing for Q4 2024, filed 16 Jan 2025.